Clinical Nutrition Open Science (Feb 2022)
Effect of preconception pictured-based health education and counseling on adherence to iron-folic acid supplementation to improve maternal pregnancy and birth outcome among women who plan to pregnant: “Randomized Control Trial”
Abstract
Summary: Background: The practice of antenatal care does not address the preconception health of future parents and should not be viewed as an isolated activity rather as a continuum of care. There is a need to develop a promotion and prevention strategy to promote optimal maternal health and future generation. Pre-conception care is a promising new preventive strategy for improving maternal and fetal health through a primary prevention approach. Although there are many ways to conduct interventions for a healthy pregnancy, pre-conception care is rarely used in Ethiopia. The aim of the proposed study is to identify the effect of pre-conceptual picture-based health education and counseling on adherence to iron-folic acid supplementation and the effect of iron-folic acid supplementation on birth outcomes. Methods: A two-arm, parallel randomized controlled community trial will be conducted among 244 women with spontaneous abortion and women planning to pregnant in Dire Dawa City Administration. Both arms receive iron-folic acid supplementation for three months, while only the intervention arm receives a treatment which is a preconception picture-based health education and counseling. Using multivariable logistic regression analyzes, the independent effect of picture-based health education and counseling on the outcome variables will be determined using both intention-to-treatment and per-protocol analyzes. Both arms will evaluate the result after one year. The primary outcome of the study is adherence to iron folic acid supplementation.This study will assess the effectiveness of preconception care counseling with iron-folic acid supplementation to increase adherence of IFAS and to avert the risk of neonates developing a neural tube defect and other adverse pregnancy and birth outcome among planned mothers to pregnant in eastern Ethiopia.This trail was registered under Clinical Trials.gov with identifier number PACTR202104543567379. The trail was registered before starting enrolment of the first case.
